{
    "eid": "2-s2.0-85131788460",
    "title": "Preclinical evaluation of a plant-derived SARS-CoV-2 subunit vaccine: Protective efficacy, immunogenicity, safety, and toxicity",
    "cover-date": "2022-07-30",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Molecular Medicine",
            "@code": "1313",
            "@abbrev": "BIOC"
        },
        {
            "@_fa": "true",
            "$": "Immunology and Microbiology (all)",
            "@code": "2400",
            "@abbrev": "IMMU"
        },
        {
            "@_fa": "true",
            "$": "Veterinary (all)",
            "@code": "3400",
            "@abbrev": "VETE"
        },
        {
            "@_fa": "true",
            "$": "Public Health, Environmental and Occupational Health",
            "@code": "2739",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Infectious Diseases",
            "@code": "2725",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "COVID-19",
        "Plant-produced subunit vaccine",
        "Protective immunity",
        "Receptor binding domain",
        "SARS-CoV-2",
        "Toxicology"
    ],
    "authors": [
        "Balamurugan Shanmugaraj",
        "Narach Khorattanakulchai",
        "Chalisa Panapitakkul",
        "Ashwini Malla",
        "Rawiwan Im-erbsin",
        "Manutsanun Inthawong",
        "Piyanate Sunyakumthorn",
        "Taweewun Hunsawong",
        "Chonticha Klungthong",
        "Matthew C. Reed",
        "Taratorn Kemthong",
        "Nutchanat Suttisan",
        "Suchinda Malaivijitnond",
        "Passaraporn Srimangkornkaew",
        "Aekkarin Klinkhamhom",
        "Suwimon Manopwisedjaroen",
        "Arunee Thitithanyanont",
        "Suthira Taychakhoonavudh",
        "Waranyoo Phoolcharoen"
    ],
    "citedby-count": 13,
    "ref-count": 73,
    "ref-list": [
        "SARS and MERS: recent insights into emerging coronaviruses",
        "COVID-19, SARS and MERS: are they closely related?",
        "The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2",
        "novel coronavirus indicating person-to-person transmission: a study of a family cluster",
        "A new coronavirus associated with human respiratory disease in China",
        "Coronavirus biology and replication: implications for SARS-CoV-2",
        "Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): an emerging zoonotic respiratory pathogen in humans",
        "SARS-CoV-2 variants: a continuing threat to global health",
        "SARS-CoV-2 mutations, vaccines, and immunity: implication of variants of concern",
        "New SARS-CoV-2 variants \u2014 clinical, public health, and vaccine implications",
        "Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera",
        "SARS-CoV-2 variants, spike mutations and immune escape",
        "Association between 3 doses of mRNA COVID-19 vaccine and symptomatic infection caused by the SARS-CoV-2 omicron and delta variants",
        "mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant",
        "Prospects for durable immune control of SARS-CoV-2 and prevention of reinfection",
        "Perspectives on monoclonal antibody therapy as potential therapeutic intervention for Coronavirus disease-19 (COVID-19)",
        "SARS-CoV-2 vaccines strategies: a comprehensive review of phase 3 candidates",
        "A comprehensive review of the global efforts on COVID-19 vaccine development",
        "Safety and immunogenicity of a recombinant tandem-repeat dimeric RBD-based protein subunit vaccine (ZF2001) against COVID-19 in adults: two randomised, double-blind, placebo-controlled, phase 1 and 2 trials",
        "Efficacy and safety of NVX-CoV2373 in adults in the United States and Mexico",
        "Vaccine adjuvants: putting innate immunity to work",
        "Subunit vaccines against emerging pathogenic human coronaviruses",
        "Immunogenicity studies of plant-produced SARS-CoV-2 receptor binding domain-based subunit vaccine candidate with different adjuvant formulations",
        "Plant-produced receptor-binding domain of SARS-CoV-2 elicits potent neutralizing responses in mice and non-human primates",
        "Guide for the Care and Use of Laboratory Animals",
        "Limited and short-lasting virus neutralizing titers induced by inactivated SARS-CoV-2 vaccine",
        "A statistically defined endpoint titer determination method for immunoassays",
        "SARS-CoV-2 jumping the species barrier: zoonotic lessons from SARS, MERS and recent advances to combat this pandemic virus",
        "SARS-CoV-2 omicron variant: Could it be another threat?",
        "Development of an inactivated vaccine candidate for SARS-CoV-2",
        "Development of an inactivated vaccine candidate, BBIBP-CorV, with potent protection against SARS-CoV-2",
        "Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques",
        "Phase 1\u20132 trial of a SARS-CoV-2 recombinant spike protein nanoparticle vaccine",
        "S-Trimer, a COVID-19 subunit vaccine candidate, induces protective immunity in nonhuman primates",
        "Developing a low-cost and accessible COVID-19 vaccine for global health",
        "Recombinant protein vaccines, a proven approach against coronavirus pandemics",
        "Contributions of the international plant science community to the fight against human infectious diseases - part 1: epidemic and pandemic diseases",
        "Potential for developing plant-derived candidate vaccines and biologics against emerging coronavirus infections",
        "Investigational new drug enabling angiotensin oral-delivery studies to attenuate pulmonary hypertension",
        "Plant-based oral vaccines against zoonotic and non-zoonotic diseases",
        "Chapter 12 - SARS-CoV-2 vaccines: current trends and prospects of developing plant-derived vaccines",
        "Plant molecular farming: a viable platform for recombinant biopharmaceutical production",
        "Emergence of novel coronavirus 2019-nCoV: need for rapid vaccine and biologics development",
        "Expression and functional evaluation of biopharmaceuticals made in plant chloroplasts",
        "Low-cost oral delivery of protein drugs bioencapsulated in plant cells",
        "Generation of glyco-engineered Nicotiana benthamiana for the production of monoclonal antibodies with a homogeneous human-like N-glycan structure",
        "Using glyco-engineering to produce therapeutic proteins",
        "Phase 1\u20132 trial of a SARS-CoV-2 recombinant spike protein nanoparticle",
        "Efficacy, immunogenicity, and safety of a plant-derived, quadrivalent, virus-like particle influenza vaccine in adults (18\u201364 years) and older adults (\u226565 years): two multicentre, randomised phase 3 trials",
        "Rapid production of SARS-CoV-2 receptor binding domain (RBD) and spike specific monoclonal antibody CR3022 in Nicotiana benthamiana",
        "Monoclonal antibodies B38 and H4 produced in nicotiana benthamiana neutralize SARS-CoV-2 in vitro",
        "Pilot production of SARS-CoV-2 related proteins in plants: a proof of concept for rapid repurposing of indoor farms into biomanufacturing facilities",
        "SARS-CoV-2 antigens expressed in plants detect antibody responses in COVID-19 patients",
        "Plant-produced SARS-CoV-2 receptor binding domain (RBD) variants showed differential binding efficiency with anti-spike specific monoclonal antibodies",
        "Development of plant-produced recombinant ACE2-Fc fusion protein as a potential therapeutic agent against SARS-CoV-2",
        "Adjuvants for Coronavirus Vaccines",
        "Alum adjuvant: some of the tricks of the oldest adjuvant",
        "COVID-19 vaccines: neutralizing antibodies and the alum advantage",
        "SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function",
        "Lethal infection of K18-hACE2 mice infected with severe acute respiratory syndrome coronavirus",
        "BNT162b vaccines protect rhesus macaques from SARS-CoV-2",
        "Immunogenicity and protective efficacy of inactivated SARS-CoV-2 vaccine candidate, BBV152 in rhesus macaques",
        "The contribution of non-human primate models to the development of human vaccines",
        "Advantages of nonhuman primates as preclinical models for evaluating stem cell-based therapies for Parkinson's disease",
        "Safety, immunogenicity, and protection provided by unadjuvanted and adjuvanted formulations of a recombinant plant-derived virus-like particle vaccine candidate for COVID-19 in nonhuman primates",
        "Phase 1 randomized trial of a plant-derived virus-like particle vaccine for COVID-19"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60016185",
            "affilname": "Armed Forces Research Institute of Medical Sciences, Thailand",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60016185",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Nakhon Pathom",
            "@id": "60012718",
            "affilname": "Mahidol University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60012718",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "117011815",
            "affilname": "Ltd.",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/117011815",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Alex Sigal",
        "Bassam Hallis",
        "Guide for the Care",
        "National Vaccine Institute, Thailand and Baiya Phytopharm Co., Ltd.",
        "National Institutes of Health",
        "National Institute of Allergy and Infectious Diseases",
        "Walter Reed Army Institute of Research",
        "NRC",
        "Chulalongkorn University"
    ]
}